BOSTON, Jan. 6,
2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE)
announced that Chris Simon,
President and CEO, will present at the 43rd Annual J.P. Morgan
Healthcare Conference in San
Francisco on Tuesday, January 14,
2025 at 5:15 pm Pacific
Time.
The public may access Mr. Simon's presentation live via audio
webcast at:
https://jpmorgan.metameetings.net/events/healthcare25/sessions/58190-haemonetics-corporation/webcast?gpu_only=true&kiosk=true
The live webcast can also be accessed under the Events &
Presentations section of Haemonetics' Investor Relations
website. The replay of the presentation will be available for 30
days using the link provided above and on Haemonetics' Investor
Relations website beginning approximately one hour after completion
of the live event.
ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global healthcare company dedicated
to providing a suite of innovative medical products and solutions
for customers, to help them improve patient care and reduce the
cost of healthcare. Our technology addresses important medical
markets: blood and plasma component collection, the surgical suite
and hospital transfusion services. To learn more
about Haemonetics, visit www.haemonetics.com.
|
Investor
Contacts:
|
|
|
Olga Guyette, Vice
President-Investor Relations & Treasury
|
David Trenk,
Manager-Investor Relations
|
|
(781) 356-9763
|
(203)
733-4987
|
|
olga.guyette@haemonetics.com
|
david.trenk@haemonetics.com
|
|
|
|
Media
Contact:
|
|
|
Josh Gitelson, Sr.
Director-Global
Communications
|
|
|
(781)
356-9776
|
|
|
josh.gitelson@haemonetics.com
|
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/haemonetics-to-present-at-43rd-annual-jp-morgan-healthcare-conference-302342258.html
SOURCE Haemonetics Corporation
